Geographic differences in healthcare costs, usage and practice are documented by research from the United States and Western Europe, yet, there is limited information on this topic in the Czech Republic. Spatial variation often seems unexplained by the demographic, health or economic characteristics of the population which points to inefficiencies in the healthcare system. We bring three main contributions: a first study dealing entirely with medical devices; we improve previously used models with a set of environmental indicators and; we work with an entirely new sample which has not been used before. Based on 2012 claims data on medical devices we present a geographic analysis of spending and further analyse spending and usage of three wi...
Accessibility of health care in the Czech Republic according to the geodemographic characteristics o...
To indicate inefficiencies in health systems, previous studies examined regional variation in health...
The thesis analyzes the determinants of pharmaceutical expenditures on cardiovascular diseases with ...
This thesis examines the regional variation in health care spending in the Czech Republic. The probl...
This thesis is focused on a comparison of an influence of geodemographic factors on costs of the med...
Abstract Background This study aims to examine the localisation of selected parameters in the deploy...
BACKGROUND: To indicate inefficiencies in health systems, previous studies examined regional variati...
Thesis introduces the health insurance system in the Czech Republic and neighbouring countries. Curr...
Geodemographic aspects of the take-up, provision, and availability of the selected healthcare servic...
Impact of demographic changes on healthcare expenditures in the Czech Republic Abstract This work ai...
This paper is a presentation of healthcare spending in Poland by the construction of spatial econom...
The graduation thesis focuses on the economics of health, particularly for medical factor -- the ava...
The Health Care Costs Analysis of Policyholders of VZP ČR Abstract The main objective of this thesis...
OBJECTIVES: Swiss health care is relatively costly. In order better to understand the drivers of ...
After joining the European Union in 2004, the post-communist countries have dramatically changed the...
Accessibility of health care in the Czech Republic according to the geodemographic characteristics o...
To indicate inefficiencies in health systems, previous studies examined regional variation in health...
The thesis analyzes the determinants of pharmaceutical expenditures on cardiovascular diseases with ...
This thesis examines the regional variation in health care spending in the Czech Republic. The probl...
This thesis is focused on a comparison of an influence of geodemographic factors on costs of the med...
Abstract Background This study aims to examine the localisation of selected parameters in the deploy...
BACKGROUND: To indicate inefficiencies in health systems, previous studies examined regional variati...
Thesis introduces the health insurance system in the Czech Republic and neighbouring countries. Curr...
Geodemographic aspects of the take-up, provision, and availability of the selected healthcare servic...
Impact of demographic changes on healthcare expenditures in the Czech Republic Abstract This work ai...
This paper is a presentation of healthcare spending in Poland by the construction of spatial econom...
The graduation thesis focuses on the economics of health, particularly for medical factor -- the ava...
The Health Care Costs Analysis of Policyholders of VZP ČR Abstract The main objective of this thesis...
OBJECTIVES: Swiss health care is relatively costly. In order better to understand the drivers of ...
After joining the European Union in 2004, the post-communist countries have dramatically changed the...
Accessibility of health care in the Czech Republic according to the geodemographic characteristics o...
To indicate inefficiencies in health systems, previous studies examined regional variation in health...
The thesis analyzes the determinants of pharmaceutical expenditures on cardiovascular diseases with ...